reamberin has been researched along with Diabetes-Mellitus--Type-2* in 3 studies
1 trial(s) available for reamberin and Diabetes-Mellitus--Type-2
Article | Year |
---|---|
[Effectiveness of Reamberin in correction of oxidative stress syndrome in patients with phlegmonous and gangrenous erysipelas against the background of the 2 type diabetes mellitus].
The influence of modern detoxic preparation Reamberin on indicators of oxidative stress syndrome (OSS)--the content of lipoperoxidation products was investigated. It was established that inclusion of Reamberin in the complex of surgical treatment of destructive forms of erysipelas on the background of type 2 DM accelerates the liquidation of OSS. Topics: Adult; Cellulitis; Diabetes Mellitus, Type 2; Erysipelas; Female; Gangrene; Humans; Male; Meglumine; Middle Aged; Oxidative Stress; Succinates; Syndrome; Treatment Outcome | 2012 |
2 other study(ies) available for reamberin and Diabetes-Mellitus--Type-2
Article | Year |
---|---|
[The use of antihypoxant therapy for the complex surgical treatment of the gangrene-ischemic diabetic foot syndrome].
Topics: Adult; Algorithms; Antioxidants; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Gangrene; Humans; Ischemia; Limb Salvage; Male; Meglumine; Middle Aged; Monitoring, Physiologic; Reoperation; Retrospective Studies; Severity of Illness Index; Succinates; Treatment Outcome | 2013 |
[Efficiency of succinic acid infusion solutions in minor surgery].
A group of 66 patients with purulent-septic surgical pathology on the background of type 2 diabetes mellitus (in the compensation phase) and atherosclerosis of vessels in lower extremities (in the decompensation phase) have been studied. The status of all patients has been determined by the syndrome of systemic inflammation reaction (rated 12.4 +/- 2.2 on the APACHE II scale). Group I (n = 30) included 19 men aged 53.7 +/-7.7 and 11 women aged 54.4 +/- 9.1, which were administered reamberin (single daily dose of 500 ml for three days after operation). Group II (n = 36) included 24 men aged 56.1 +/- 9.2 and 12 women aged 51.9 +/- 8.8 with analogous pathology and general status, which received infusion therapy without reamberin. It is established that the administration of reamberin in patients with purulent-septic surgical pathology on the background of type 2 diabetes mellitus and atherosclerosis of vessels in lower extremities is patho-. genetically justified and allows the reperfusion syndrome upon various operations to be prevented and the critical state in post-operation regime to be eliminated. Topics: Adult; Aged; Atherosclerosis; Diabetes Mellitus, Type 2; Female; Humans; Male; Meglumine; Middle Aged; Succinates; Systemic Inflammatory Response Syndrome; Time Factors | 2013 |